NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
01/27/2026
Back to search
Official data from USPTO
ADD
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: US
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
32
Latest update
01/28/2026
Classification
Registered
Trademark type
Word
Nice classes
9, 35, 42
Filing date
03/29/2023
Registration date
01/27/2026
Expiration date
-
Recommended action
Perform a full collision analysis and validate classes before any filing or trademark investment.
Next step
These are the details of the registration process. Even so, constant monitoring is what ensures peace of mind that your main asset remains protected.
Complete case details
Structured fields from the responsible authority and the official record.
Status date
01/27/2026
Last transaction
01/28/2026
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
Filing basis
Foreign priority
Drawing code
4
Owner type
11
Owner location
Mumbai, Maharashtra, IN
Examiner
MARCY, AMY ALFIERI
Law office
L90
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
TATA CONSULTANCY SERVICES LIMITED
Representatives
Charles T. J. Weigell FROSS ZELNICK LEHRMAN & ZISSU, P.C.
Technical classification
Nice Classes
Class 9Class 35Class 42
Vienna Codes
No Vienna codes available.
Goods and services
Class 9
Downloadable computer software platform used for collecting and analyzing data in the field of healthcare and optimization of healthcareclinical and hospital processes; downloadable computer software and downloadable computer firmware used for automating control of medical equipment; downloadable computer software for information managementdata collection and data analysis of medical equipmentall of the above for pharmaceuticallife sciencesmedical devices and healthcare providers; downloadable computer software for clinical trials and drug development; downloadable computer software for database analysis and management; computer hardware and downloadable software for use with medical patient monitoring equipmentfor receivingprocessingtransmitting and displaying data; downloadable computer software platform for pharmacovigilance that enables automation of case processing and supports diverse data source formats; downloadable computer software to automate drug regulatory processes and compliance with drug registration; downloadable computer software for controlling and managing patient medical information
Class 35
Business consulting and management in the field of clinical trialsclinical data and regulatory submission management on behalf of medicalbiopharmaceutical and biotechnology companies to assist them with clinical researchclinical trialsdrug development and applications for drug approval; Computerized file management includes data related to drug developmentregulatory compliancepharmacovigilance
Class 42
Scientific researchstudy and research consultation in the fields of medicinedrug deliveryclinical trialsdrug development; laboratory research in the field of new drug development; Design and development of computer software for pharmacovigilancemedicinedrug deliveryclinical trialsdrug developmentautomate drug regulatory processes and compliance with drug registration; online non-downloadable computer software to provide aforementioned services using artificial intelligence and machine learning techniques; Providing a web site featuring technology enabling physicians to access resources in clinical medicine; Research and development of vaccines and medicines; Consultancy relating to quality control; Advisory services relating to all the aforesaid services; online non-downloadable computer software services for pharmacovigilance; scientific and technological servicesscientific and medical research in the fields of pharmaceuticaldrug developmentclinical trialslife sciencesmedical devices; Software as a Service (SaaS) featuring software for data collectiondata management and data analyticsPlatform as a Service (PaaS) featuring software for data collectiondata management and data analytics in the fields of medicinedrug deliveryclinical trialsdrug developmentautomate drug regulatory processes and compliance with drug registration; online non-downloadable computer software for data collectiondata management and data analytics in the fields of medicinedrug deliveryclinical trialsdrug developmentautomate drug regulatory processes and compliance with drug registration using artificial intelligence and machine learning techniques
Publications
History of USPTO decisions and trademark events.
32 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
01/27/2026
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
12/09/2025
PUBO
PUBLISHED FOR OPPOSITION
12/09/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
12/03/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
11/12/2025
RCCK
SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
11/04/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
10/09/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
10/09/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
10/09/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
05/03/2025
GNSL
LETTER OF SUSPENSION E-MAILED
05/03/2025
CNSL
SUSPENSION LETTER WRITTEN
05/03/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
03/20/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
03/20/2025
ERSI
TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
03/20/2025
GNS2
NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
01/07/2025
GNSI
INQUIRY TO SUSPENSION E-MAILED
01/07/2025
CNSI
SUSPENSION INQUIRY WRITTEN
01/07/2025
GNS3
NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
03/10/2024
GNSL
LETTER OF SUSPENSION E-MAILED
03/10/2024
CNSL
SUSPENSION LETTER WRITTEN
03/10/2024
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
01/26/2024
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
01/25/2024
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
01/25/2024
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
01/16/2024
GNRT
NON-FINAL ACTION E-MAILED
01/16/2024
CNRT
NON-FINAL ACTION WRITTEN
01/16/2024
DOCK
ASSIGNED TO EXAMINER
12/21/2023
PARI
TEAS VOLUNTARY AMENDMENT RECEIVED
10/16/2023
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
04/20/2023
NWAP
NEW APPLICATION ENTERED
04/01/2023
Continuous trademark protection
Get notified about every new filing that threatens ADD or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.